000 06118cam a2200421Mi 4500
001 94917
003 ES-MaUEC
005 20230102112638.0
006 m o d
007 cr |n|||||||||
008 161125s2017 sz o 001 0 eng d
020 _a331941559X
_q(electronic bk.)
020 _a9783319415598
_q(electronic bk.)
020 _z3319415573
_q(print)
020 _z9783319415574
_q(print)
035 _a(OCoLC)964379118
_z(OCoLC)970806811
_z(OCoLC)971036711
_z(OCoLC)971079836
_z(OCoLC)973766098
_z(OCoLC)973795161
_z(OCoLC)974651002
_z(OCoLC)981113258
_z(OCoLC)981869199
_z(OCoLC)982140883
_z(OCoLC)982230844
_z(OCoLC)982363836
_z(OCoLC)1005787110
040 _aYDX
_cYDX
_dN$T
_dIDEBK
_dEBLCP
_dGW5XE
_dOCLCF
_dN$T
_dAZU
_dUAB
_dCOO
_dOCLCQ
_dUPM
_dVT2
_dIOG
_dMERER
_dESU
_dZ5A
_dOCLCQ
_dJBG
_dIAD
_dICW
_dICN
_dOTZ
_dOCLCQ
_dU3W
_dES-MaUEC
_bspa
050 4 _aRC660
_b2017 EB
245 0 0 _aDiabetes mellitus in developing countries and underserved communities
_cSam Dagogo-Jack, editor.
264 1 _aCham, Switzerland
_bSpringer International Publishing
264 4 _c2017
300 _a1 recurso en línea
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aPreface; Contents; Contributors; About the Editor; 1: The Global Burden of€Diabetes: An€Overview; Introduction; References; 2: Primary Prevention of€Type 2 Diabetes: An€Imperative for€Developing Countries; Introduction; Risk Factors for€Type 2 Diabetes; Pathophysiology; Prediabetes; Predictors of€Progression from€Prediabetes to€Type 2 Diabetes; Predictors of€Initial Transition to€Prediabetes; Rationale for€Primary Prevention of€Type 2 Diabetes; Unique Vulnerabilities in€Developing Countries; Approach to€Prevention of€Type 2 Diabetes; Lifestyle Modification; Da Qing Study.
505 8 _a5: Diabetes in€China and€the€Western Pacific Region Introduction; Rapid Transition and€the€Obesity Epidemic; Unique Aspects of€Pathophysiology: Beta-Cell Function Versus€Visceral Obesity; Genomic Landscape of€Diabetes in€the€Region; Nature Versus Nurture; Morbidity and€Mortality; Emerging Epidemic of€Young-Onset Diabetes and€Its Comorbidities; Diagnosis of€Diabetes and€Prediabetes in€Asia; Translating Primary Prevention of€Type 2 Diabetes; Western Pacific Diabetes Declaration (WPDD) Plan for€Action (2006-2010).
505 8 _aEpidemiology of€Diabetes in€MENA Prevalence of€Diabetes; Prevalence of€Diabetes Complications; Risk Factors for€Type 2 Diabetes in€the€MENA Region; Obesity; Genetics of€Diabetes; Physical Inactivity; Chronic Hepatitis C Infection; Pesticide Exposure; Cultural Factors Affecting Type 2 Diabetes in€the€MENA Region; Dietary Pattern; Sedentary Lifestyle; Smoking; Health Illiteracy; Poor Adherence; Healthcare Quality; Prevention of€T2D; Future Directions; Strategies to€Improve Diabetes Care in€the€MENA Region; Summary and€Conclusions; References.
505 8 _aFinnish Diabetes Prevention Study Diabetes Prevention Program; Indian Diabetes Prevention Program; Translating Diabetes Prevention to€Communities in€Developing Countries; Keys to€Translation; Dissemination of€Diabetes Prevention Knowledge; Strategies for€Diabetes Prevention in€the€Community; Community Diabetes Prevention Centers; Medications for€Diabetes Prevention; Limitations of€Medications; Current Guidelines for€Use of€Medication for€Diabetes Prevention; Costs of€Preventing T2DM; References; 3: Diabetes in€Sub-Saharan Africa; Overview; Epidemiology of€Diabetes in€Africa.
505 8 _aHistorical Perspective Current Trends; Risk Factors for€Diabetes in€Africa [9]; Age, Gender and€Family History; Ethnicity, Urbanisation, Migration and€Diabetes; Diabetes and€Obesity; Adiposity; Physical Activity, Diet and€Diabetes; Impact of€HIV/AIDS; Clinical Manifestations; Economic Cost of€Diabetes; Healthcare Access for€Diabetes and€its Complications; Advocacy and€Policy for€Diabetes Control and€Prevention; Future Perspectives of€Diabetes Prevention and€Control; References; 4: Type 2 Diabetes in€the€Middle East and€North Africa (MENA); Introduction.
520 3 _aAdopting a truly global perspective and a practical approach to diabetes--including pathophysiology, genetics, regional peculiarities, management, prevention and best practices--this book is an excellent resource for clinicians and policy-makers working with patients in more austere settings. The global prevalence of diabetes is estimated to increase from 422 million in 2014 to 592 million in 2035. Sadly, low- and middle-economy countries are projected to experience the steepest increase, but even in developed economies, vulnerable demographic subgroups manifest disparities in diabetes prevalence, quality of care, and outcomes. This book extends coverage to those underserved and minority communities in the developed world. In a consistent chapter format, it discusses classification, pathophysiology, genomics, diagnosis, prevention and management of diabetes in economically challenged regions as well as underserved populations in affluent nations. Suggestions regarding future directions in the organization of diabetes care delivery, prevention and research priorities are also provided. The detailed identification of barriers to optimal care and the practical approach to the management and prevention of diabetes make Diabetes Mellitus in Developing Countries and Underserved Communities a valuable resource for clinicians, researchers and health policy leaders.
650 7 _aDiabetes.
_2fast
_0(OCoLC)fst00892147
_9138582
_0comprobar BNE19900961602
700 1 _aDagogo-Jack, Sam,
_d1954-
_eeditor literario
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-41559-8
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988 _aSpringer_Medicine_2017
998 _b02/2018
_dz
_e-
_zSI
999 _c94917
_d94917
_x1